Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Relapse Multiple Myeloma Clinical Trials

3 recruiting trials for Relapse Multiple Myeloma. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
1
Phase 3 Trials
3
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT06138275

Elranatamab in R/R Multiple Myeloma

This research is being done to see if the study drug, elranatamab, reduces the risk of disease progression (worsening disease) after idecabtagene vicleucel in relapsed refractory...

Sponsor: Massachusetts General HospitalEnrolling: 323 locations
RECRUITINGPhase 3NCT06561854

Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

Patients with relapsed/refractory symptomatic multiple myeloma who meet all inclusion criteria, will be randomized 1:1 to receive either standard of care chemotherapy (IKEMA or...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 3181 location
RECRUITINGPhase 1NCT07093554

Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in...

This is a single-arm, open-label, phase 1b study evaluating the safety and feasibility of using talquetamab as bridging therapy prior to cilta-cel in patients with relapsed and...

Sponsor: Medical College of WisconsinEnrolling: 311 location